Cumberland Partners LTD Astrazeneca PLC Transaction History
Cumberland Partners LTD
- $1.19 Billion
- Q1 2025
A detailed history of Cumberland Partners LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Cumberland Partners LTD holds 125,344 shares of AZN stock, worth $9.27 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
125,344
Previous 4,611
2618.37%
Holding current value
$9.27 Million
Previous $302,000
2950.33%
% of portfolio
0.78%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.22 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.01 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...